Cancer Council have launched a new nationwide campaign to increase participation in the National Bowel Cancer Screening Program (NBCSP). This campaign is thanks to $10 million received from the Federal Government to encourage more Australians to screen.
The NBCSP is one of Australia’s most important public health programs. The program has the potential to prevent 83,800 bowel cancer deaths by 2040 if program participation increases to 60%. In 2016-2017, only 41.3% of eligible Australians participated in the NBCSP.
We will target Australians aged 50-74 through TV, radio, outdoor, and digital advertising and encourage them to do the at-home test when they receive it in the mail.
Health professionals are integral to the success of this campaign and the NBCSP. Evidence shows that a recommendation during consultation is a key motivator to screen. You can promote participation through:
- Endorsing the program by displaying brochures and posters,
- Encouraging patients aged 50-74 to do the test by:
- Undertaking an audit of practice records and sending a letter or SMS to under- screened patients aged 50-74 encouraging participation,
- Demonstrating how to use the NBCSP kit with eligible patients,
- Sending a letter or SMS to patients nearing their 50th birthday to encourage them to complete the test when they first receive it.
Resources to help health professionals support this campaign, including tips for encouraging participation, instructional videos, clinical guidelines and FAQs, are available at http://www.cancerscreening.gov.au/health-professionals.
The Quitline is already receiving calls from people seeking help to quit vaping.
Cancer Council's Responding to Emotions in Cancer course has been developed to support clinical staff to manage difficult conversations.
The Clinical Network Executive Committee welcomes a new Chair and Co-Chair and identifies priority areas for its work informing Cancer Council Victoria's policy and advocacy objectives.
Self-administered cancer tests are marketed as a way for people to take control of their health, but they may actually be undermining trust in evidence-based testing and putting people at risk.